122 | MATSUZAKA eT Al.Our patient presented with two contradictory aspects: (a) She CONFLICT OF INTERESTmet criteria for PDD according to the DSM-5 but did not meet None.criteria for bipolar disorder; and (b) although she did not show im-provement with antidepressant treatment, remission was achieved AUTHOR CONTRIBUTIONSfollowing therapy with a mood stabilizer, lamotrigine. There are Yu. M. treated the patient and drafted the manuscript. Yo. M. criti-several guidelines that recommend mood stabilizers for treating pa- cally reviewed the draft and revised it. All authors made substan-tients with depressive disorder based on the recognition of bipolar tial contributions, drafted the manuscript, and approved the finaldisorder as a broad-spectrum disorder that encompasses depressive manuscript.disorder.7–9 Moreover, PDD is thought to be a predictive factor forbipolar disorder, alongside family history of bipolar disorder and cy- INFORMED CONSENTclothymic temperament.10 Therefore, the concepts of bipolar disor- Written consent from the patient was obtained.der and PDD need to be considered carefully.There has been limited discussion around the use of mood stabi- DATA AVAILABILITY STATEMENTlizers for the treatment of PDD. Most mood stabilizers are effective Data sharing is not applicable to this article as no datasets were gen-for managing manic states, but they are not effective for resolving erated or analyzed during the current study.depressive states. However, lamotrigine is effective for the treat-ment of bipolar depression and has a low risk of manic switch.11 ORCIDFurthermore, lamotrigine has a therapeutic effect on depressive Yusuke Matsuzaka https://orcid.org/0000-0002-3552-7297cognition and psychomotor retardation in patients with bipolar Yoshiro Morimoto https://orcid.org/0000-0002-0636-277Xdepression.12 Therefore, the use of lamotrigine in the treatment of Hirohisa Kinoshita https://orcid.org/0000-0002-9077-1612PDD may be useful in regard to efficacy and safety. In animal mod-els, the blocking of sodium channels was related to improving de- REFERENCESpressive symptom.13 1. Carta MG, Paribello P, Nardi AE, Preti A. Current pharmacothera-Interestingly, our patient presented with depression-related peutic approaches for dysthymic disorder and persistent depres-sive disorder. Expert Opin Pharmacother. 2019;20(14):1743–54.anxiety, which also improved with lamotrigine. Anxiety frequently2. von Wolff A, Hölzel LP, Westphal A, Härter M, Kriston L. Selectivecoexists with depression, and the addition of benzodiazepines to an- serotonin reuptake inhibitors and tricyclic antidepressantstidepressant treatment is common practice in treatments for major in the acute treatment of chronic depression and dysthy-depression. Reports have shown that combination therapy with anti- mia: a systematic review and meta-analysis. J Affect Disord.2013;144(1–2):7–15.depressants and benzodiazepines is more effective than antidepres-3. Santaguida PL, MacQueen G, Keshavarz H, Levine M, Beyene J,sant monotherapy for improving the severity, treatment response, Raina P. Treatment for Depression After Unsatisfactory Responseand remission in the early stages of depression.14 However, in our to SSRIs [internet]. Rockville (MD): Agency for Healthcarecase, combination therapy of antidepressants and benzodiazepines Research and Quality (US) Report No.: 12-EHC050-EF; 2012 Apr.Available from: https://www.ncbi.nlm.nih.gov/books/NBK97was not effective. Moreover, animal models have revealed that lam-406/otrigine has an anxiolytic-like pharmacokinetic profile that may be 4. Cohen J. Assessment and treatment of dysthymia. The devel-related to sodium channels.15 Taken together, we suggest that lamo- opment of the Cornell dysthymia rating scale. Eur Psychiatry.trigine is a promising alternative to benzodiazepines in the treatment 1997;12(4):190–3.5. Amann B, Born C, Crespo JM, Pomarol-Clotet E, McKenna P.of PDD.Lamotrigine: when and where does it act in affective disorders? AThe plasma concentration of lamotrigine has not been measured systematic review. J Sychopharmacol. 2011;25(10):1289–94.in this case. Therapeutic response to lamotrigine occurs when its 6. Reid JG, Gitlin MJ, Altshuler LL. Lamotrigine in psychiatric disor-plasma concentration is higher than 12.7 μmol/L.16 This response ders. J Clin Psychiatry. 2013;74(7):675–84.was derived in 75-100 mg dosage, so our patient might have suffi- 7. Ghaemi SN. Bipolar spectrum: a review of the concept and a visionfor the future. Psychiatry Investig. 2013;10(3):218–24.cient therapeutic effect of lamotrigine with 200 mg.8. Hantouche EG, Angst J, Akiskal HS. Factor structure of hypomania:In summary, our case demonstrated that lamotrigine may be ef- interrelationships with cyclothymia and the soft bipolar spectrum.fective in patients with PDD who are resistant to antidepressants. J Affect Disord. 2003;73(1–2):39–47.Moreover, lamotrigine may be a promising alternative to combination 9. Akiskal HS. Validating 'hard' and 'soft' phenotypes within the bi-polar spectrum: continuity or discontinuity? J Affect Disord.therapy of antidepressants and benzodiazepines in the treatment2003;73(1–2):1–5.of PDD. Fully understanding the homogeneity and heterogeneity 10. Takeshima M, Oka T. A comprehensive analysis of features thatof bipolar disorder and PDD requires further clinical and biological suggest bipolarity in patients with a major depressive episode:investigations. Nevertheless, we believe that our case provides an which is the best combination to predict soft bipolarity diagnosis? JAffect Disord. 2013;147(1–3):150–5.opportunity to further our understanding of these disorders.11. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E,Rudd GD. A double-blind placebo-controlled study of lamotrigineACKNOWLEDGMENT monotherapy in outpatients with bipolar I depression. Lamictal 602We thank the patient for participating in this study. Study Group. J Clin Psychiatry. 1999;60(2):79–88.